Do you know if the company is reaching out to congressmen that had previously voiced support for approving Actipatch and if BIEL is trying to organize political pressure regarding this decision?
Seems like the FDA has a lot to answer for considering they approved a new opiate 1000x stronger than morphine in a rushed and expedited session less than a month ago but can't seem to find the cajonez when approving this side-effect free device.
Wish these 2 examples were printed side by side in the media to illuminate the FDA incompetence in promoting and mismanaging the opioid epidemic.
mtoronto, if one is reading between the lines here, one could assume that since BioElectronics tweeted the FDA update AND also posted it on their Facebook page, it isn’t necessarily bad news? I’ve never seen them post bad news to social media before. Just my thoughts, though.